How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

​We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.

from Economic Times https://ift.tt/dsGoSBr